Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-599-5 | CAS number: 587-26-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Neurotoxicity
Administrative data
Description of key information
The results from an unpublished developmental neurotoxicity study by Shire (2010), and the absence of adverse findings in FOB results of a 90-day repeated dose study suggest a NOAEL of 2000 mg/kg bw/day Lanthanum carbonate for neurotoxic effects.
Key value for chemical safety assessment
Effect on neurotoxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- NOAEL
- 2 000 mg/kg bw/day
Additional information
Functional observations (FOB) additionally including approach response, touch response, auditory response, tail pinch response, righting reflex, grip strength and landing foot splay as well as motor activity assessments were performed in the course of a reliable subchronic feeding study conducted according to OECD 408 in rats dosed with Lanthanum carbonate octahydrate after oral intake at doses up to and including 14000 ppm (Reißmüller, 2006; for details refer to section 5.6.1 or IUCLID section 7.5.1). No treatment-related effects were observed in the test battery, except for the observation of a non dose-dependent tilted head in single animals and an occasional slightly increased number of rearing. These effects were not considered treatment related because of the absence of a dose response.
Furthermore, there is an unpublished (The registrant contacted Shire Pharmaceuticals in order to achieve the legitimate posession (LoA) of this study. The company did not agree to share the data.) developmental neurotoxicity study performed according to OECD 426 (Shire, 2010; FDA 2004). In this study, time-mated female Sprague-Dawley rats were orally exposed to Lanthanum carbonate from implantation (GD 6) throughout lactation (PND 20) at doses of 200, 600, 1000 or 2000 mg/kg bw/d. In this study some neurological parameters were also investigated:), static righting reflex (PND5), startle response (PND15), papillary reflex (PND 21). After weaning 20 F1 pups/sex/group were selected randomly for detailed post weaning examinations and rearing and sexual maturity. The remaining pups were necropsied. The selected pups were observed daily for clinical signs. Body weights were recorded weekly. Ophthalmologic examinations auditory function assessment were performed on PND 28 to 35 and E-maze learning assessment on PND 28. There were no effects of maternal treatment on the righting, startle or pupillary light reflexes. Furthermore, there were no treatment-related effects on E-maze learning, auditory function or ophthalmoscopy.
Neurological behaviour was also investigated in an acute inhalation study with Wistar rats exposed to 5928 mg/m³ Lanthanum carbonate octahydrate for 4 hours (Pauluhn, 2005). In comparison to the rats of the control group, none of the rats of the exposure group exhibited a change in reflexes (visual placing response and grip strength on wire mesh, abdominal muscle tone, corneal and pupillary reflexes, pinnal reflex, righting reflex, tail-pinch response, startle reflex with respect to behavioural changes stimulated by sounds (finger snapping) and touch (back)).
Justification for classification or non-classification
The data on neurotoxicity is conclusive but not sufficient for classification according to the criteria of Directives 67/548/EEC (DSD) and 1272/2008/EC (CLP).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.